Company Encyclopedia
View More
name
HUALAN NPM
301093.SZ
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. engages in the research and development, manufacture, and sale of packaging materials for the pharmaceuticals industry in China and internationally. It offers covered rubber stoppers series; halogenated butyl rubber stopper freeze-dryied series; halogenated butyl rubber stopper antibiotics series; halogenated butyl rubber stopper transfusion series; combination cap series for plastic infusion vessel; polyisoprene gaskets; blood plugs; halogenated butyl rubber stopper for oral dosage forms; pre-potted protective caps; medical instruments; and pen style products. The company was founded in 1992 and is based in Jiangyin, China.
353.29 B
301093.SZMarket value -Rank by Market Cap -/-

Financial Score

20/11/2025 Update
C
Health Care SuppliesIndustry
Industry Ranking22/41
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE2.30%C
    • Profit Margin8.37%B
    • Gross Margin39.20%B
  • Growth ScoreC
    • Revenue YoY2.18%C
    • Net Profit YoY-37.36%D
    • Total Assets YoY1.80%C
    • Net Assets YoY-2.39%D
  • Cash ScoreC
    • Cash Flow Margin1194.16%B
    • OCF YoY2.18%C
  • Operating ScoreD
    • Turnover0.24D
  • Debt ScoreA
    • Gearing Ratio13.48%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    In the year, important shareholders increased their holdings by over 93 billion yuan, setting a new high since 2023

    Since November, multiple A-share listed companies have announced shareholding increase plans. Huangtai Wine's controlling shareholder intends to increase holdings by 70 million to 140 million yuan, JSCN's controlling shareholder plans to increase holdings by 100 million to 150 million yuan, and HUALAN NPM's controlling shareholder aims to increase holdings by 30 million to 60 million yuan. According to statistics, as of November 19, the total amount of shareholding increases by important shareholders of A-share companies has exceeded 93 billion yuan this year, setting a new high since 2023. (Securities Times)

    36Kr·
    SH
    600959
    -0.56%
    SZ
    301093
    +0.13%
    SZ
    000995
    -2.17%
    36Kr·
    SH
    600959
    -0.56%
    SZ
    301093
    +0.13%
    SZ
    000995
    -2.17%

    HUALAN NPM newly established a smart pharmaceutical technology company, including AI business

    According to the Qichacha APP, recently, Hainan Lingqing Smart Pharmaceutical Technology Co., Ltd. was established with a registered capital of 50 million yuan. The business scope includes: artificial intelligence industry application system integration services; artificial intelligence application software development; artificial intelligence public data platform; artificial intelligence basic software development, etc. Qichacha's equity penetration shows that the company is wholly owned by HUALAN NPM

    Zhitong·
    SZ
    301093
    +0.13%
    Zhitong·
    SZ
    301093
    +0.13%

    HUALAN NPM released its performance for the first three quarters, with a net profit attributable to the parent company of 53.316 million yuan, an increase of 2.06%

    HUALAN NPM released its third-quarter report for 2025, with operating revenue for the first three quarters amounting to 441 million yuan, a year-on-year increase of 4.36%. The net profit attributable to the parent company was 53.316 million yuan, a year-on-year increase of 2.06%. The net profit after deducting non-recurring gains and losses was 40.8258 million yuan, a year-on-year increase of 13.66%. The basic earnings per share were 0.325 yuan

    Zhitong·
    SZ
    301093
    +0.13%
    Zhitong·
    SZ
    301093
    +0.13%

    HUALAN NPM: Net profit in the third quarter was 9.5839 million yuan, a year-on-year decrease of 37.20%

    HUALAN NPM announced that the revenue for the third quarter was 132 million yuan, a year-on-year decrease of 4.72%; the net profit was 9.5839 million yuan, a year-on-year decrease of 37.20%. The revenue for the first three quarters was 441 million yuan, a year-on-year increase of 4.36%; the net profit was 53.316 million yuan, a year-on-year increase of 2.06%

    Zhitong·
    SZ
    301093
    +0.13%
    Zhitong·
    SZ
    301093
    +0.13%

    HUALAN NPM plans to establish a subsidiary in Hainan with an investment of 50 million yuan, focusing on research and development solutions and services for innovative drugs in artificial intelligence

    According to the Zhitong Finance APP, HUALAN NPM announced that the company plans to use its own funds of 50 million yuan to invest in establishing a wholly-owned subsidiary in Hainan Province. The main business scope of this wholly-owned subsidiary will be: research and development solutions and services for innovative drugs in artificial intelligence

    Zhitong·
    SZ
    301093
    +0.13%
    Zhitong·
    SZ
    301093
    +0.13%